ALAMEDA, Calif., February 23, 2015 – ESI BIO, the stem cell products division of BioTime, Inc., providing stem cells and stem cell research reagents world-wide, and Pivotal Scientific Ltd, a company specializing in developing the international growth of biotech enterprises, announced an alliance agreement to develop business opportunities and manage ESI BIO’s growing network of new international distributors.
ESI BIO’s (esibio.com) research products are used by stem cell researchers around the world and include clinical and research grade human embryonic stem cells from ES Cell International (ESI) and HyStem® hyaluronan-based hydrogel extracellular matrices. ESI BIO also provides unique PureStem® embryonic progenitors, antibodies, and small molecules for stem cell differentiation and reprogramming.
Under the new agreement, Pivotal Scientific will use its experience and contacts in the biologic research field to develop opportunities for ESI BIO and will handle a network of new distributors for ESI BIO products. “ESI BIO has a lot to offer researchers,” said James Mosedale, Business Development Director, at Pivotal, “not just in terms of excellent products, but their focus on clinically-relevant products is a novel selling point, especially as researchers are looking to treat and cure disease. We’re looking forward to doing our best to get these products into the hands of more researchers worldwide.”
“We’re very pleased to have signed this agreement to have Pivotal Scientific working on our behalf,” said Jeffrey Janus, CEO of ESI BIO. “Pivotal Scientific can help us develop our world-wide distribution network, and has the right combination of experience and contacts to make our distribution strategies succeed.”
About ESI BIO
ESI BIO - A division of BioTime, Inc., is a unique research reagent organization which markets and distributes stem cell related research products provided by BioTime and its subsidiary companies. Many of these products can be provided as a research grade or clinical grade, including ES Cell International’s human embryonic stem cell lines and HyStem® hyaluronan-based hydrogels produced under conditions designed to be compliant with principles of current Good Manufacturing Practices (cGMP), making them suitable for use in clinical research and regenerative medicine. ESI BIO's portfolio includes PureStem® human embryonic progenitors, antibodies, and small molecules for stem cell differentiation and reprogramming. ESI BIO's mission is to develop innovative research products that help translate scientific discoveries to the clinic. ESI BIO facilities are located in La Jolla and Alameda, California. Learn more at www.esibio.com.
About Pivotal Scientific Ltd
Pivotal Scientific Ltd (PSL) is a consultancy working specifically with manufacturers developing reagents for life science research. PSL works with start-ups to help develop their business, sales and marketing strategies, with small and medium enterprises looking to take the next step and grow internationally and larger companies looking to acquire other companies. Learn more at www.pivotalscientific.com.
ESI BIO - A Division of BioTime, Inc.
Jeffrey Janus, CEO
T: 510-521-3390 x376
Pivotal Scientific Ltd.
James Mosedale, Business Development Director
T: +44(0)1869 23877